Share Capital

1. Share Capital

The main events in the capital history of the Company from 1 December 2002 to the date of this document is as follows:

  • On 1 December 2002, the authorised share capital of the Company was £2,000,000 divided into 8,000,000 ordinary shares of 25p each, of which 857,142 ordinary shares of 25p each were in issue fully paid or credited as fully paid
  • On 1 December 2002, the authorised share capital of the Company was £2,000,000 divided into 8,000,000 ordinary shares of 25p each, of which 857,142 ordinary shares of 25p each were in issue fully paid or credited as fully paid
  • Between December 2002 and May 2004, 5,662,220 ordinary shares of 25p each were issued to raise approximately £3.6 million.
  • On 31 January 2006 the Company converted its CULS into ordinary shares of 25p on 31 January 2006 at a rate of £2.00 per share
  • On 7 February and 3 March 2006, 13,311,990 new Ordinary Shares were placed  to raise approximately €39 million
  • 27 January 2006 the authorised share capital of the Company was increased to £5,000,000 divided into 20,000,000 ordinary shares of 25p each 
  • 24 February 2006 the authorised share capital of the Company was increased to £30,000,000 divided into 120,000,000 ordinary shares of 25p each 
  • On 20 June 2006 the authorised and issued share capital of the Company was subdivided into 600,000,000 Ordinary Shares of 5p each 
  • On 12 June 2009 96,760,349 new Ordinary Shares were placed  to raise approximately £11.6 million.
  • On 16 July 2009 the new Chief Executive Officer, Rowen Bainbridge, subscribed for 180,000 new ordinary shares of 5 pence each at the 14 pence per share.
  • On 3 February 2010, 106,433,438 new Ordinary Shares were placed  to raise approximately €39 million.

The Company is currently authorised to issue up to 600,000,000 Ordinary Shares of which 339,495,249 are in issue.

Since 1 December 2002 the following shares have been issued:

 

Date(s) of Issue

Number of 25p
ordinary shares*

Consideration Received

1 December 2002

857,142

 Outstanding shares

31 December 2002 to 5 March 2003

3,503,541 

 £0.635 per 25p share in cash

25 March 2004
to 27 May 2004

2,158,679 

 £0.635 per 25p share in cash

31 January 2006

830,207 

 Conversion of CULS at £2 per 25p share

6 February 2006 

10,000,000 

 Placing at £2.30 per 25p share in cash

3 March 2006 

621,319 

 Rights issue at £2.30 per 25p share

6 March 2006 

2,690,671 

 Placing at £2.30 per 25p share

19 June 2006 

40,000

 £0.635 per 25p share in cash on the exercise of Options 

20 June 2006 

20,701,559

 Total shares in issue

 

Number of 5p
ordinary shares*

 

20 June 2006

103,507,795

 Shares in issue after subdivision

1 August 2006

7,748,085

 Exercise of warrants

15 August 2006

22, 970,582

 £0.55 per 5 pence share in cash on listing on AIM

April / May 2007

475,000

 £0.127 per share in cash on exercise of Options

25 January 2008

800,000

 £0.127 per share in cash on exercise of options

25 June 2008

100,000

 £0.127 per share in cash on exercise of options

12 June 2008

96,760,349

 £0.12 per share in cash

16 July 2008

180,000

 £0.14 5p pence in cash

31 December 2009

220,000

 £0.165 per 5p share in cash on exercise of Option

31 December 2009

300,000

 £0.17 per 5p share in cash on exercise of Option

3 February 2010

106,433,438

 £0.32 per 5p share in cash

4 February 2010

339,495,249

 Total 5p shares in issue

 

 Note: On 20 June 2006 each ordinary share of 25p was subdivided into 5 Ordinary Shares; the issues post that date therefore are expressed in relation to 5p Ordinary Shares.

 

2. Substantial Shareholding

After the allotment of shares on 3 February 2010.

 

Shares 000's 

 

Lord Sainsbury of Preston Candover KG

43,960,718 

12.9%

Kulczyk Investments S.A.

34,272,014

10.1%

Fidelity International Limited

28,655,156

8.4%

Palo Alto Investors

27,787,778 

8.2%

Toscafund Asset Management

21,832,500

6.4%

Ingalls & Snyder

19,365,930

5.7%

Blue Ridge

12,985,4373.8%

Integrated Core Strategies (Europe) s.a.r.l.

12,525,000 3.3%
Contessa*10,945,485
3.2%
Total shares in issue

339,495,249 

 

*Contessa is beneficially owned by Mr Donnelly who is a Director

3. Directors Declarable Interests

 

Director

Number of shares held

 

 

Beneficial

Non beneficial

 

Rowen Bainbridge 383,125 
Mark Reid 203,125 
David Walker 78,125 
Dariusz Mioduski 34,272,014
Miles Donnelly 10,945,485 
Nicholas Coats 30,24043,960,718
Malcolm Pattinson 638,900 
David Prior 2,381,345 
Michael Seymour 5,143,6902,408,937

Total

19,804,035

80,641,669

 

 

 

 

 

 

 

 

 

 

4. Warrants and options

In August 2006, the Company issued warrants to advisers pursuant to the listing of the entire issued share capital on AIM.

Number

Exercise Price

Expiry Date

2,013,397

£0.55p

21 August 2011


There are 10,359,712 options to management and staff outstanding.

 

5. Shares under Control of the Board

At the General Meeting held on 3 February 2010, the following resolution was passed:

3   That in substitution for all subsisting authorities to the extent unused, the Directors be and they are hereby empowered pursuant to section 570 and section 573 CA 2006 to allot equity securities (within the meaning of section 560 CA 2006) as if section 561 CA 2006 did not apply to any such allotment, provided that this power shall be limited to: 

  • a) the allotment of equity securities of up to an aggregate nominal value of £6,000,000, being the maximum aggregate nominal amount of the Placing Shares in connection with the Placing as described in the Circular;
  • b) the allotment of equity securities in connection with an issue or offering in favour of holders of equity securities and other persons entitled to participate in such issue or offering where the equity securities respectively attributable to the interests of such holders and persons are in proportion (as nearly as may be practicable) to their existing holdings and to holders of other equity securities as required by the rights of those securities or as the Directors otherwise consider necessary, and so that the Directors may impose any limits or restrictions and make any arrangements which they consider necessary or appropriate to deal with any treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or under the laws of, any territory or the requirements of any regulatory body or stock exchange or any other matter (including any such problems arising by virtue of equity securities being represented by depositary receipts); and
  • c) the allotment (otherwise than under paragraphs (a) and (b) of this Resolution 3) of equity securities up to an aggregate nominal amount of £1,765,309,

and this Resolution 3 shall expire at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution 3 or 30 June 2011, whichever is the earlier, except that the Company may before such expiry make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of such offer or agreement as if the power conferred hereby had not expired.

6. Share Transfer Limitations

There are currently no restrictions on the transfer of AIM Securities. 
7. Shares not in Public Hands 
As far as the Company is aware, the percentage of AIM Securities that is not in public hands is 30%   

Due to legal restrictions, the contents of the following web pages may not be accessed by persons who are located in the United States, Canada, Australia, Japan or South Africa.


The information contained on this section of the website is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States. The shares have not been and will not be registered under the Securities Act, or with any other securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or delivered within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable states securities laws. Nor does it constitute an offer of, or an invitation to buy, securities in any jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such an offer or invitation.


While the Company has taken reasonable care to ensure that the information on this website (other than information accessed by hyperlink) is accurate at the time of last revision of the website, the Company accepts no liability for the accuracy or completeness or use of, nor any liability to update, the information contained on this website. It should not be construed as the giving of advice or the making of a recommendation and should not be relied on as the basis for any decision or action. In particular, actual results and developments may be materially different from any forecast, forward-looking statement, opinion or expectation expressed on this website.


None of the information contained on the following pages nor any copy thereof may be taken or transmitted in or into the United States or distributed, directly or indirectly, in or into the United States. Persons present in the United States of America are not permitted to access this section of the website and should exit it immediately.


By clicking the “SUBMIT” button below you (i) certify that you are not located in the United States, Canada, Australia, Japan or South Africa and (ii) acknowledge that you have read and understood the notices and disclaimers set forth above.

This presentation has been prepared by Wood Mackenzie for Aurelian Oil & Gas. This presentation does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for or otherwise acquire, any securities of the Company or of any subsidiary or subsidiary undertaking of the Company, nor does this presentation constitute or form part of any invitation or inducement to engage in investment activity under section 21 of the Financial Services and Markets Act 2000, nor does it constitute a recommendation regarding securities of the Company, nor shall it or any part of it form the basis of or be relied on in connection with any contract or investment decision. If you are considering engaging in any investment activity, you should seek appropriate independent financial advice and make your own assessment.